on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Life Science REIT plc
The Vanguard Group, Inc. has filed a Form 8.3, revealing a stake in Life Science REIT plc. The disclosure is in accordance with Rule 8.3 of the Takeover Code, as Vanguard holds a 1% interest in relevant securities. The specific securities are the 1p ordinary shares, amounting to 3,511,201 shares.
The filing indicates a recent sale of 2,982 shares at 0.43 GBP each. No new subscriptions or cash-settled derivatives were reported. Vanguard clarified that no indemnity or agreements related to these securities are in place.
Additionally, the company reported no arrangements concerning voting rights or future acquisitions. As of May 14, 2025, there were no supplemental forms attached to the disclosure, marking a straightforward declaration of interests by Vanguard.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news